Cargando…
Reslizumab in the treatment of inadequately controlled asthma in adults and adolescents with elevated blood eosinophils: clinical trial evidence and future prospects
Eosinophils have long been implicated as playing a central role in the pathophysiology of asthma in many patients, and eosinophilic asthma is now recognized as an important asthma endotype. Eosinophil differentiation, maturation, migration, and survival are primarily under the control of interleukin...
Autor principal: | Máspero, Jorge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933654/ https://www.ncbi.nlm.nih.gov/pubmed/28683596 http://dx.doi.org/10.1177/1753465817717134 |
Ejemplares similares
-
Role of biologics in severe eosinophilic asthma – focus on reslizumab
por: Pelaia, Girolamo, et al.
Publicado: (2016) -
Update on new biologics for intractable eosinophilic asthma: impact of reslizumab
por: Sahota, Jagdeep, et al.
Publicado: (2018) -
Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?
por: Varricchi, Gilda, et al.
Publicado: (2017) -
Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma
por: Walsh, Garry M
Publicado: (2013) -
Successful treatment of refractory eosinophilic fasciitis with reslizumab
por: Mortezavi, Mahta, et al.
Publicado: (2020)